Literature DB >> 22820875

Prognosis of resected pancreatic cancer: is the refined resection margin status dispensable?

Werner Hartwig, Jens Werner, Markus W Büchler.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22820875     DOI： 10.1007/s00423-012-0968-y

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN： 1435-2443            Impact factor:   3.445


× No keyword cloud information.
  8 in total

1.  The "artery first" approach for resection of pancreatic head cancer.

Authors:  Jürgen Weitz; Nuh Rahbari; Moritz Koch; Markus W Büchler
Journal:  J Am Coll Surg       Date:  2009-12-03       Impact factor: 6.113

2.  Uncinate process first--a novel approach for pancreatic head resection.

Authors:  Thilo Hackert; Jens Werner; Jürgen Weitz; Jan Schmidt; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2010-06-27       Impact factor: 3.445

3.  Most pancreatic cancer resections are R1 resections.

Authors:  Irene Esposito; Jörg Kleeff; Frank Bergmann; Caroline Reiser; Esther Herpel; Helmut Friess; Peter Schirmacher; Markus W Büchler
Journal:  Ann Surg Oncol       Date:  2008-03-20       Impact factor: 5.344

4.  Redefining the R1 resection in pancreatic cancer.

Authors:  C S Verbeke; D Leitch; K V Menon; M J McMahon; P J Guillou; A Anthoney
Journal:  Br J Surg       Date:  2006-10       Impact factor: 6.939

5.  Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Nigel B Jamieson; Alan K Foulis; Karin A Oien; James J Going; Paul Glen; Euan J Dickson; Clem W Imrie; Colin J McKay; Ross Carter
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

6.  Pancreatic cancer surgery in the new millennium: better prediction of outcome.

Authors:  Werner Hartwig; Thilo Hackert; Ulf Hinz; Alexander Gluth; Frank Bergmann; Oliver Strobel; Markus W Büchler; Jens Werner
Journal:  Ann Surg       Date:  2011-08       Impact factor: 12.969

7.  Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head?

Authors:  M S Janot; S Kersting; O Belyaev; A Matuschek; A M Chromik; D Suelberg; W Uhl; A Tannapfel; U Bergmann
Journal:  Langenbecks Arch Surg       Date:  2012-06-14       Impact factor: 3.445

8.  Margin clearance and outcome in resected pancreatic cancer.

Authors:  David K Chang; Amber L Johns; Neil D Merrett; Anthony J Gill; Emily K Colvin; Christopher J Scarlett; Nam Q Nguyen; Rupert W L Leong; Peter H Cosman; Mark I Kelly; Robert L Sutherland; Susan M Henshall; James G Kench; Andrew V Biankin
Journal:  J Clin Oncol       Date:  2009-04-27       Impact factor: 44.544
  8 in total
  2 in total

1.  [Resection plus adjuvant chemotherapy improves survival in advanced pancreatic adenocarcinoma].

Authors:  S E Combs; J Werner
Journal:  Strahlenther Onkol       Date:  2013-02       Impact factor: 3.621

2.  HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.

Authors:  Jian Yang; Xu Zhang; Yi Zhang; Dongming Zhu; Lifeng Zhang; Ye Li; Yanbo Zhu; Dechun Li; Jian Zhou
Journal:  J Exp Clin Cancer Res       Date:  2016-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.